Debt-to-equity of Tenaya Therapeutics, Inc. from 31 Mar 2022 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Tenaya Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2022 to 31 Dec 2025.
  • Tenaya Therapeutics, Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 22%, a 2.3% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Tenaya Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 22% -0.52% -2.3% 31 Dec 2025
Q3 2025 24% +3.2% +15% 30 Sep 2025
Q2 2025 24% +4.6% +24% 30 Jun 2025
Q1 2025 24% +5.8% +32% 31 Mar 2025
Q4 2024 22% +5.3% +31% 31 Dec 2024
Q3 2024 21% +5.8% +38% 30 Sep 2024
Q2 2024 19% +4.4% +30% 30 Jun 2024
Q1 2024 18% +3.4% +24% 31 Mar 2024
Q4 2023 17% +2.7% +19% 31 Dec 2023
Q3 2023 15% +1.6% +12% 30 Sep 2023
Q2 2023 15% +2.8% +23% 30 Jun 2023
Q1 2023 15% -2.2% -13% 31 Mar 2023
Q4 2022 14% 31 Dec 2022
Q3 2022 14% 30 Sep 2022
Q2 2022 12% 30 Jun 2022
Q1 2022 17% 31 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.